Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking During Abstinence

NCT07328594 is registered in ClinicalTrials.gov with Legacy Health System as lead sponsor.

NCT NCT07328594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking During Abstinence
Lead sponsor
Legacy Health System
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 10, 2026
Completion date
September 30, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, insomnia, nicotine, sleep, smoking, substance use disorders, tobacco